title: Letter from the editor.
authors.affiliation: a Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel.
authors.forename: Ronald W
authors.initials: RW
authors.lastname: Ellis
authors.forename: Eva M
authors.initials: EM
authors.lastname: Riedmann
mesh_terms: D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D055808:Drug Discovery / Q000639:trends; D006801:Humans; D017780:Malaria Vaccines / Q000008:administration & dosage / Q000276:immunology*; D055118:Medication Adherence; D010342:Patient Acceptance of Health Care; D014611:Vaccination / Q000379:methods*; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D001428:Bacterial Vaccines; D017780:Malaria Vaccines; D014765:Viral Vaccines